Therapy Areas: Autoimmune
26 September 2022 - - China-based commercial stage biopharmaceutical company InnoCare Pharma (HKEX: 09969) has received acceptance of the biologics license application for tafasitamab in combination w...
26 September 2022 - - US-based clinical-stage immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) will host an R and D Day featuring clinical data presentations on ALPN-303, a potentiall...
23 September 2022 - Pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) announced on Friday that Ultomiris (ravulizumab) has been approved by European regulators as an add-on to st...
22 September 2022 - - US-based biotech company Abpro has forged a strategic partnership with South Korean biopharmaceutical company Celltrion for its cancer molecule ABP 102, an antibody therapy ...
21 September 2022 - - China-based commercial stage biopharmaceutical company InnoCare Pharma (HKEX: 09969) has received acceptance of the biologics license application for tafasitamab in combination w...
21 September 2022 - - US-based clinical-stage immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) will host an R and D Day featuring clinical data presentations on ALPN-303, a potentiall...
Related Headlines